TikTok peptide searches go blank for semaglutide BPC 157 and retatrutide

TikTok peptide searches for a handful of popular names now lead nowhere. Since around October 20, typing semaglutide, BPC 157 or retatrutide into the app's search box has returned a page saying no results were found, The Verge reported. The videos themselves have not been removed, the general word peptides still brings up many clips, and the company has not announced or explained the change. For sellers who rely on the app to find buyers, it is a narrow but visible new barrier.

What changed in the app

The Verge reported that the block covers semaglutide, BPC 157, retatrutide and several other peptide names, and that each now returns an empty results page. Republished versions of the report and other outlets named the same three terms. A user post that helped draw attention to the change, from the creator Jeff Tang, said searches for melanotan also came back empty and that a search for a short form of retatrutide showed eating disorder support resources instead, a claim we could not check independently. The change appears to affect search only. Reporters found no clear sign that existing videos were taken down, and the popular combination sold online as the Wolverine stack did not show up under its exact names.

The block is also easy to get around. Slight misspellings and small variations of the restricted names still surfaced videos, according to the reports, and the app's own search suggestions offered workable variants before a user finished typing. TikTok's US owner did not immediately respond to a request for comment from The Verge, and the platform has not published a list of affected terms or a reason for the change. That leaves open whether this is a test, a permanent search restriction, or the first step toward removing promotional videos. It also leaves sellers and creators guessing which words will be next, since no rule has been posted for them to follow.

Why an approved drug name is on the list

The three names are not alike. Semaglutide is the active ingredient in Ozempic and Wegovy, medicines approved by the FDA and other regulators for diabetes and weight management. BPC 157 is not approved as a medicine anywhere and has little human data behind it. Retatrutide is still being tested in clinical trials and has not been licensed by any medicines regulator in the world, Daily Maverick reported this week. By treating all three the same way, the search block hides patient talk about an approved drug alongside sales pitches for compounds that are not approved. One possible reason, which TikTok has not confirmed, is that sellers use the approved name too when they market copies of semaglutide.

By treating all three the same way, the search block hides patient talk about an approved drug alongside sales pitches for compounds that are not approved.

There is a precedent on the same app. Last year TikTok blocked the SkinnyTok hashtag from search and pointed users to the National Alliance for Eating Disorders after lawmakers raised concerns about body image, according to a YPulse summary of the coverage. If the report about eating disorder resources holds, the peptide change may follow the same playbook, where search is limited for a term linked to weight loss without banning the topic itself. That approach lowers casual discovery, especially for younger users, but it does little against creators who already have large followings and post links directly to their audience, or who simply move the same content to other apps.

What it means for peptide sellers

For peptide sellers, TikTok peptide searches have been a cheap route to new buyers. Marketing analysts at eMarketer said the restriction could lead to closer oversight of promotions, affiliate deals and seller links across social platforms, though TikTok has not said it plans any such step. The FDA has been moving on the same channel from the regulatory side. It sent warning letters to five online peptide vendors in August, according to a Holland and Knight legal alert, and it has earlier pursued FDA warning letters against online clinics that advertised GLP 1 drugs. A search block is not a legal finding, but it adds friction to a market that depends on reach.

The timing matters because federal policy on some of these compounds is in flux. HHS and the FDA sent an interim policy on compounding certain peptides to the White House budget office in October, and reports say it could let pharmacies mix BPC 157 for a time. Even if that happens, it would cover licensed pharmacies, not products sold as research chemicals through social media links. Our gray market coverage tracks those sellers, who often sell products labelled for research use to stay outside drug rules. A blank search page does not change what is legal, and buyers in this channel still face the risk of the wrong substance, the wrong strength or contamination.

What patients and doctors should watch

For patients, the change mostly removes one easy way to find seller content, while honest information about approved drugs gets harder to find too. People prescribed semaglutide who look for patient experiences in the app may now see an empty page, and doctors may hear about the block from patients who assume it signals a safety problem with their medicine. It does not. The restriction says nothing about the approved drugs themselves, and no regulator has linked it to any new safety finding. Prescribers who want to steer patients away from social media claims can point them to the drug label, the pharmacist and the prescriber, which remain the reliable sources.

The open questions are about scope and permanence. TikTok peptide searches may widen to more names, the company could start removing promotional videos, or the block could fade quietly, as some platform tests do. Readers should also expect sellers to adapt with new spellings, since the reports show that variants already work. We will update this story if TikTok publishes a policy or explains which terms it restricts and why. Until then, the change is best read as a limited search restriction reported by journalists and users, not as a confirmed platform policy with written rules that apply to every creator and every seller on the app.

Conclusion

TikTok peptide searches for semaglutide, BPC 157 and retatrutide now return a blank page, but the videos remain and simple misspellings still work. The company has not explained the change. For gray market sellers it adds friction, for patients on approved drugs it adds confusion, and for regulators it changes nothing in law. Watch for a written TikTok policy, a wider list of terms, or video removals. This story is news, not medical advice.